Findings

What do systematic reviews say?

4 questions · 6 findings · 1 reviews · Back and Neck · Headline outcomes only

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 16.7%High 5 · 83.3%

Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Patients with acute low‐back pain

2 findings from 1 review

Paracetamol for low back pain 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1520 participants
High
Paracetamol for low back pain 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1526 participants
High

Disability 1 week (immediate term) (RMDQ 0 to 24) · Patients with acute low‐back pain

2 findings from 1 review

Paracetamol for low back pain 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1511 participants
High
Paracetamol for low back pain 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1522 participants
High

Any adverse events Up to 12 weeks' · Patients with acute low‐back pain

Paracetamol showed no clear difference in any adverse events Up to 12 weeks' compared with placebo (high certainty).

1 finding from 1 review

Paracetamol for low back pain 2016 · Cochrane Headline outcomes only
RR 1.07 [0.86, 1.33]
1 study · 1624 participants
High

Serious adverse events Up to 12 weeks' · Patients with acute low‐back pain

Paracetamol showed no clear difference in serious adverse events Up to 12 weeks' compared with placebo (moderate certainty).

1 finding from 1 review

Paracetamol for low back pain 2016 · Cochrane Headline outcomes only
RR 0.9 [0.3, 2.67]
1 study · 1643 participants
Moderate